Related Experiment Video
Updated: Aug 8, 2026

12:50
Procedure for Lung Engineering
Published on: March 8, 2011
Bioprinted cell-instructive lung-dECM constructs for reconstructing an immuno-regenerative pulmonary microenvironment
1BioFab Lab, Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, Telangana, 502285, India.
Biomaterials
|August 6, 2026
Summary
Researchers developed novel decellularized lung matrix (dLM) bioinks for pulmonary tissue engineering. These dLM bioinks offer high printing fidelity and support regenerative cell responses, creating a validated platform for lung tissue engineering.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Tissue Engineering
Background:
- Pulmonary tissue engineering demands scaffolds with mechanical compliance and instructive cues.
- Soft biomaterials often compromise printing fidelity.
- Decellularized lung matrix (dLM) offers potential but requires optimized processing.
Purpose of the Study:
- To develop and characterize decellularized lung matrix (dLM) bioinks for pulmonary tissue engineering.
- To investigate the impact of processing strategies on dLM bioink properties and printability.
- To evaluate the regenerative potential of printed dLM scaffolds in directing cell fate and modulating immune responses.
Main Methods:
- Osmotic decellularization strategy to preserve extracellular matrix (ECM) components like sulfated glycosaminoglycans (sGAGs).
- Print-matched thixotropy testing to standardize extrusion conditions and predict post-extrusion recovery.
- Bioprinting of dLM hydrogels and assessment of cytocompatibility and cell differentiation (mesenchymal stem cells, macrophages).
Main Results:
- dLM bioinks reconciled print fidelity with lung parenchymal viscoelasticity.
- Collagen-dominant dLM inks showed superior layer stacking; sGAG-rich matrices exhibited rapid viscosity rebuild.
- Printed scaffolds directed mesenchymal stem cell differentiation and promoted anti-inflammatory macrophage polarization.
Conclusions:
- Strategic preservation of lung ECM components yields printed scaffolds with high fidelity and regenerative capacity.
- dLM bioinks provide a compositionally validated platform for engineering lung tissue.
- The developed bioinks support niche-specific cell responses and in vitro immunomodulation.

